MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$4,160K
EPS
-$2.94
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Research and development
2,558
2,587
2,361
2,593
General and administrative
1,592
1,600
2,687
3,071
Total operating expense
4,150
4,187
5,048
5,664
Loss from operations
-4,150
-4,187
-5,048
-5,664
Interest expense-Nonrelated Party
29
33
31
29
Grant income
-
-
-
0
Change in fair value of other liabilities and derivatives-Related Party
-
-3
7
1
Interest expense-Related Party
6
5
10
23
Change in fair value of other liabilities and derivatives-Nonrelated Party
1
-45
93
18
Other income (expense), net
31
73
18
-22
Total other income (expense), net
-5
83
-123
-93
Loss before income taxes
-4,155
-4,104
-5,171
-5,757
Income tax provision
5
4
10
4
Net loss
-4,160
-4,108
-5,181
-5,761
Net loss attributable to noncontrolling interest
-
-
-32
-46
Net loss attributable to controlling interest
-4,160
-4,108
-5,149
-5,715
Deemed dividend on warrants
-
-309
-5,673
0
Net loss attributable to common stockholders
-4,160
-4,417
-10,822
-5,715
Basic EPS
-2.94
-0.43
-2.21
-1.99
Diluted EPS
-2.94
-0.43
-2.21
-1.99
Basic Average Shares
1,416,000
10,308,000
4,907
2,877
Diluted Average Shares
1,416,000
10,308,000
4,907
2,877
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$4,160K
(27.21%↑ Y/Y)
Net loss
attributable to controlling...
-$4,160K
(27.21%↑ Y/Y)
Net loss
-$4,160K
(27.79%↑ Y/Y)
Loss before income
taxes
-$4,155K
(27.83%↑ Y/Y)
Income tax provision
$5K
(25.00%↑ Y/Y)
Loss from operations
-$4,150K
(26.73%↑ Y/Y)
Total other income
(expense), net
-$5K
(94.62%↑ Y/Y)
Other income
(expense), net
$31K
(240.91%↑ Y/Y)
Total operating
expense
$4,150K
(-26.73%↓ Y/Y)
Interest
expense-Nonrelated Party
$29K
(0.00%↑ Y/Y)
Interest
expense-Related Party
$6K
(-73.91%↓ Y/Y)
Change in fair value of
other liabilities and...
$1K
(-94.44%↓ Y/Y)
Research and development
$2,558K
(-1.35%↓ Y/Y)
General and
administrative
$1,592K
(-48.16%↓ Y/Y)
Buy us a coffee
Calidi Biotherapeutics, Inc. (CLDWW)
Calidi Biotherapeutics, Inc. (CLDWW)